Corrigendum to the EGM Notice dated 8th June 2026

Parmax Pharma Ltd has issued a corrigendum to its Extraordinary General Meeting (EGM) notice dated June 8, 2026, which was called for a preferential issue of equity shares and convertible warrants. The corrigendum corrects the proposed status of Ms. Sheetal Hiren Doshi in the warrant allottees table from 'Promoter*' to 'Promoter Group*'. Additionally, a hyperlink for the Practicing Company Secretary’s Certificate in the explanatory statement has been rectified. All other items of the EGM Notice remain unchanged, with the EGM scheduled for July 2, 2026.